1. Marcus FI, Fontaine GH, Guiraudon G et al (1982) Right ventricular dysplasia: A report of 24 adult cases. Circulation 65:384-398

2. Thiene G, Nava A, Corrado D et al (1988) Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 318:129-133

3. Corrado D, Basso C, Thiene G et al (1997) Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: A multicenter study. J Am Coll Cardiol 30:1512-1520

4. Fontaine G, Fontaliran F, Frank R (1998) Arrhythmo-genic right ventricular cardiomyopathies: Clinical forms and main differential diagnoses. Circulation 97:1532-1535

5. Nava A, Bauce B, Basso C et al (2000) Clinical profile and long-term follow-up of 37 families with arrhyth-mogenic right ventricular cardiomyopathy. J Am Coll Cardiol 36:2226-2233

6. McKenna WJ, Thiene G, Nava A et al (1994) Diagnosis of arrhythmogenic right ventricular dysplasia/car-diomyopathy. Br Heart J 71:215-218

7. Marcus FI, Towbin JA, Zareba W et al (2003) Arrhyth-mogenic right ventricular dysplasia/cardiomyopathy (ARVD/C): A multidisciplinary study - Design and protocol. Circulation 107:2975-2978

8. Basso C, Wichter T, Danieli GA et al (2004) Arrhyth-mogenic right ventricular cardiomyopathy: Clinical registry and database, evaluation of therapies, pathology registry, DNA banking. Eur Heart J 25:531-534

9. Wichter T, Hindricks G, Lerch H et al (1994). Regional myocardial sympathetic dysinnervation in arrhyth-mogenic right ventricular cardiomyopathy: An analysis using 123I-Meta-Iodobenzylguanidine scintigraphy. Circulation 89:667-683

10. Wichter T, Schäfers M, Borggrefe M et al (2000) Abnormalities of cardiac sympathetic innervation in ar-rhythmogenic right ventricular cardiomyopathy: Quantitative assessment of presynaptic norepinephrine re-uptake and postsynaptic ß-adrenoceptor density using positron emission tomography. Circulation 101:1552-1558

11. Daliento L, Turrini P, Nava A et al (1995) Arrhythmo-genic right ventricular cardiomyopathy in young ver-

sus adult patients: Similarities and differences. J Am Coll Cardiol 25:655-664

12. Corrado D, Basso C, Pavei A et al (2006) Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA 296:1593-1601

13. Gerull B, Heuser A, Wichter T et al (2004) Mutations in the desmosomal arm repeat protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet 36:1162-1164

14. Garcia-Gras E, Lombardi R, Giocondo MJ et al (2006) Suppression of canonical Wnt/b-catenin signaling by nuclear plakoglobin recapitulates phenotype of ar-rhythmogenic right ventricular cardiomyopathy. J Clin Invest 116:2012-2021

15. Kirchhof P, Fabritz L, Zwiener M et al (2006) Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice. Circulation 114:1799-1806

16. Wichter T, Paul M, Breithardt G (2005) Arrhythmo-gene rechtsventrikuläre Kardiomyopathie: Sportmedizinische Aspekte. Dtsch Z Sportmed 56:118-125

17. Corrado D, Basso C, Thiene G (1996) Pathological findings in victims of sport-related sudden cardiac death. Sports Exerc Injury 2:78-86

18. Blomström-Lundqvist C, Sabel KG, Olsson SB (1987) A long-term follow up of 15 patients with arrhythmo-genic right ventricular dysplasia. Br Heart J 58:477-488

19. Canu G, Atallah G, Claudel JP et al (1993) Prognostic et évolution à long terme de la dysplasie arythmogène du ventricule droit. Arch Mal Coeur 86:41-48

20. Leclercq JF, Coumel P, Denjoy I et al (1991) Long-term follow-up after sustained monomorphic ventricular tachycardia: Causes, pump failure, and empiric antiarrhythmic therapy that modify survival. Am Heart J 121:1685-1692

21. Marcus FI, Fontaine GH, Frank R et al (1989) Long-term follow-up in patients with arrhythmogenic right ventricular disease. Eur Heart J 10:68-73

22. Turrini P, Corrado D, Basso C et al (2003) Noninvasive risk stratification in arrhythmogenic right ventricular cardiomyopathy. Ann Noninvasive Electrocardiol 8:161-169

23. Dalal D, Nasir K, Bomma C et al (2005) Arrhythmo-genic right ventricular dysplasia: A United States experience. Circulation 112:3823-3832

24. Hulot S, Jouven X, Empana JP et al (2004) Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation 110:1879-1884

25. Wichter T, Paul M, Eckardt L et al (2005) Arrhythmogenic right ventricular cardiomyopathy: Antiarrhythmic drugs, catheter ablation, or ICD. Herz - Cardiovasc Dis 30:91-101

26. Peters S, Peters H, Thierfelder L (1999) Risk stratification of sudden cardiac death and malignant ventricular arrhythmias in right ventricular dysplasia-car-diomyopathy. Int J Cardiol 71:243-250

27. Lemola K, Brunckhorst C, Helfenstein U et al (2005) Predictors of adverse outcome in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: Long term experience of a tertiary care centre. Heart 91:1167-1172

28. Kiès P, Bootsma M, Bax J et al (2006) Arrhythmogenic right ventricular dysplasia/cardiomyopathy: Screening, diagnosis, and treatment. Heart Rhythm 3:225-234

29. Turrini P, Corrado D, Basso C et al (2001) Dispersion of ventricular depolarization-repolarization. A noninvasive marker for risk stratification in arrhythmogenic right ventricular cardiomyopathy. Circulation 103:3075-3080

30. Corrado D, Leoni L, Link MS et al (2003) Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 108:3084-3091

31. Wichter T, Paul M, Wollmann C et al (2004) Implantable cardioverter-defibrillator therapy in ar-rhythmogenic right ventricular cardiomyopathy: Single-center experience oflong-term follow-up and complications in 60 patients. Circulation 109:1503-1508

32. Piccini JP, Dalal D, Roguin A et al (2005) Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia. Heart Rhythm 2:1188-1194

33. Pezawas T, Stix G, Kastner J et al (2006) Ventricular tachycardia in arrhythmogenic right ventricular dys-plasia/cardiomyopathy: Clinical presentation, risk stratification and results of long-term follow-up. Int J Cardiol 107:360-368

34. Fontaine G, Zenati O, Tonet J et al (1997) The treatment of ventricular arrhythmias. In: Nava A, Rossi L, Thiene G (eds) Arrhythmogenic right ventricular cardiomyopathy/dysplasia. Elsevier Science, Amsterdam, BV:315-363

35. Tonet J, Frank R, Fontaine G et al (1989) Efficacité de l'association de faibles doses de bêta-bloquants à l'amiodarone dans le traitment des tachycardies ven-triculaires réfractaires. Arch Mal Coeur 82:1511-1517

36. Berder V, Vauthier M, Mabo P et al (1995) Characteristics and outcome in arrhythmogenic right ventricular dysplasia. Am J Cardiol 75:411-415

37. Wichter T, Borggrefe M, Haverkamp W et al (1992) Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia. Circulation 86:29-37

38. Hamid MS, Norman M, Quraishi A et al (2002). Prospective evaluation of relatives for familial ar-rhythmogenic right ventricular cardiodmyopathy/dys-plasia reveals a need to broaden diagnostic criteria. J Am Coll Cardiol 40:1445-1450

39. Wichter T, Breithardt G (2005) Implantable car-dioverter-defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: A role for genotyping in decision-making? J Am Coll Cardiol 45:409-411

Was this article helpful?

0 0

Post a comment